Abstract
Objectives: The aim of this study was to evaluate the relation between pathology, operative complications and giant ovarian tumor weighing more than 5,000 g. Materials and Methods: We assessed eleven factors of 18 patients with giant ovarian tumors after surgery, including age, Performance Status (PS), total weight of the tumor, fluid weight of the tumor, pathology, side, preoperative serum D-dimer, rate of Deep Venous Thrombosis (DVT), intraoperative complications (rate of intra-abdominal adhesion and blood loss weight), and rate of postoperative ICU management. The subjects were divided into two groups: tumor weight ≥10,000 g (group ≥10,000 g) and tumor weight <10,000 g (group <10,000 g), and the same factors were compared between two groups. Results: The most frequent pathology of giant ovarian tumors weighing more than 5,000 g was found to be adenocarcinoma. Compared with eleven patients of group<10,000 g, seven patients out of group ≥10,000 g had significantly higher PS (median: 3 vs. 1, p<0.05), rate of intra-abdominal adhesion (85.7% vs. 9.0%, p<0.05), fluid weight (15.000 g vs. 4.400 g, p<0.05), blood loss weight (890 g vs. 130 g, p<0.05), and rate of postoperative ICU management (85.7% vs. 18.2%, p<0.05), respectively. Conclusions: Much attention should be paid to patients with giant ovarian tumors who confined to bed more than 50% of waking hours (PS 3 or 4), and aggressive surgery is recommended due to a frequent incidence of cancer.
Highlights
The definition of giant ovarian tumors has not been established
Because almost reports on giant ovarian tumors were published as a case report, there is no information concerning the comprehensive data about the pathology and operative complications of giant ovarian tumors
We divided the patients into two groups: tumor weight ≥10,000 g and tumor weight
Summary
The definition of giant ovarian tumors has not been established. The size of giant ovarian tumors can be diagnosed by transverse and vertical diameter by Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) before surgery. One author defined giant ovarian tumors as those measuring more than 10 cm with preoperative scans (1), whereas another author defined giant ovarian tumors as those reaching above the umbilicus (2). There are few reports evaluating giant ovarian tumors by their weight after surgery. It is unknown whether the most frequent pathology of giant ovarian tumors is benign or not. Because almost reports on giant ovarian tumors were published as a case report, there is no information concerning the comprehensive data about the pathology and operative complications of giant ovarian tumors
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
